Submitted:
28 February 2025
Posted:
03 March 2025
You are already at the latest version
Abstract
Background/Objectives: Currently, the Meares-Stamey 4-glass and the 2-glass tests are used for diagnosing chronic prostatitis subtypes. Both tests include prostatic massage. Failure to extract prostatic secretions -for any reason- results in an undiagnostic test. Evidence from everyday practice and studies shows that expressed prostatic secretion is successfully recovered in less than 50% of the examined patients and an important number of post-massage urine samples are missing prostatic secretions. This study evaluated a simpler test, the 3-glass (pre-ejaculation, ejaculation, and post-ejaculation) test. We compared it with the 4-glass and the 2-glass tests to detect inflammation and bacteria in men with chronic prostatitis symptoms. Methods: The study population included patients with chronic prostatitis symptoms. Subjects were assigned in each visit to undergo either the 4-glass or the 2-glass test or the 3-glass test. The comparison among the three tests was based on the percentage of bacterial detection, the percentage of false negative diagnoses, and the percentage of shifts among chronic prostatitis subtypes in the follow-up visits of recurrent patients. Results: A total of 157 patients were finally evaluated. Fifty-nine (59) patients underwent the 4-glass test (group A), sixty-seven (67) underwent the 3-glass test (group B) and thirty-one (31) underwent the 2-glass test (group C). No statistically significant differences in the aforementioned comparisons were found. Conclusions: A comparison of the three diagnostic tests showed no superiority of the total ejaculate culture-based 3-glass test to the conventional prostatic secretions culture-based tests.
Keywords:
1. Introduction
2. Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
Abbreviations
| EPS | Expressed prostatic secretion |
| TE | Total ejaculate |
| VB1 | first-void urine |
| VB2 | second-void urine |
| VB3 | third-void urine |
| PoPM | post-prostate massage |
| PoE | post ejaculate |
| PrPM | pre-prostate massage |
| PrE | pre-ejaculate |
References
- Stamatiou K, Karageorgopoulos DE. A prospective observational study of chronic prostatitis with emphasis on epidemiological and microbiological features. Urologia. 2013;80(3):225-32. [CrossRef]
- Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JE Jr, Zeitlin S, O'Leary MP, Pontari MA, Schaeffer AJ, Landis JR, Nyberg L, Kusek JW, Propert KJ. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006;176(1):119-24. [CrossRef]
- Rizzo M, Marchetti F, Travaglini F, Trinchieri A, Nickel JC. Prevalence, diagnosis and treatment of prostatitis in Italy: a prospective urology outpatient practice study. BJU Int. 2003;92(9):955-9. [CrossRef]
- Stamatiou K, Samara E, Lacroix RN, Moschouris H, Perletti G, Magri V. One, No One and One Hundred Thousand: Patterns of chronic prostatic inflammation and infection. Exp Ther Med. 2021;22(3):966. [CrossRef]
- Stamatiou K, Magri V, Perletti G, Samara E, Christopoulos G, Trinchieri A. How urologists deal with chronic prostatitis? The preliminary results of a Mediterranean survey. Arch Ital Urol Androl. 2020;92(4). [CrossRef]
- Pendegast HJ, Leslie SW, Rosario DJ. Chronic Prostatitis and Chronic Pelvic Pain Syndrome in Men. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK599550/#.
- Krieger JN, Ross SO, Riley DE. Chronic prostatitis: epidemiology and role of infection. Urology. 2002;60(6 Suppl):8–12. [CrossRef]
- Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ. Chronic Prostatitis Collaborative Research Network Study Group. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol. 2003;170(3):818-22. [CrossRef]
- Solomon M, Henkel R. Semen culture and the assessment of genitourinary tract infections. Indian J Urol. 2017;33(3):188-193. [CrossRef]
- Mobley DF. Semen cultures in the diagnosis of bacterial prostatitis. J Urol. 1975;114:83–5. [CrossRef]
- Budía A, Luis Palmero J, Broseta E, Tejadillos S, Benedicto A, Queipo JA, Gobernado M, Fernando Jiménez Cruz J. Value of semen culture in the diagnosis of chronic bacterial prostatitis: a simplified method. Scand J Urol Nephrol. 2006;40(4):326-31. [CrossRef]
- McNaughton Collins M, Fowler FJ, Jr, Elliott DB, Albertsen PC, Barry MJ. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test. Urology. 2000;55:403–7.
- Sutcliffe S, Giovannucci E, De Marzo AM, Willett WC, Platz EA. Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms. Am J Epidemiol. 2005;162(9):898-906.
- Magri V, Wagenlehner FM, Montanari E, Marras E, Orlandi V, Restelli A, Torresani E, Naber KG, Perletti G. Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications. Asian J Androl. 2009;11(4):461-77. [CrossRef]
- Zegarra Montes LZ, Sanchez Mejia AA, Loza Munarriz CA, Gutierrez EC. Semen and urine culture in the diagnosis of chronic bacterial prostatitis. Int Braz J Urol. 2008;34(1):30-7.
| Mean Age | Mean NIH-CPSS | |
|---|---|---|
| 4 glass Meares-Stamey test | 51.4 | 17.5 |
| 3 glass test | 48.7 | 20.4 |
| 2 glass test | 49.2 | 17.4 |
| p>0.05 | p>0.05 |
| Group A: 4 glass test | Diagnosis | N° | % |
|---|---|---|---|
| N = 27 |
CBP | 13 | 48.1 |
| CNBNI | 6 | 22.2 | |
| CNBI | 5 | 18.5 | |
| C&CBP | 1 | 3.7 | |
| PCB | 3 | 11.1 | |
| Other | 1 | 3.7 | |
| Group B: 3 glass test | Diagnosis | N° | % |
| N = 35 |
CBP | 20 | 57.1 |
| CNBNI CNBI C&CBP PCB Other |
5 | 14.2 | |
| 4 | 11.4 | ||
| 4 | 11.4 | ||
| 1 | 2.8 | ||
| 1 | 2.8 | ||
| Group C: 2 glass test | Diagnosis | N° | % |
| N = 12 |
CBP CNBNI CNBI C&CBP PCB Other |
7 | 58.3 |
| 3 | 25 | ||
| 0 | 0 | ||
| 1 | 8.3 | ||
| 1 | 8.3 | ||
| 0 | 0 |
| Group A: 4 glass test | T | U | CBP | CNBI | CNBNI | C&CBP | PCB |
| CBP | 12 | 3 | 1 | 1 | |||
| CNBI | 1 | 2 | 1 | 2 | |||
| CNBNI | 6 | 1 | |||||
| C&CBP | 2 | ||||||
| PCB | 1 | ||||||
| Group B: 3 glass test | T | U | CBP | C-NBI | CNBNI | C&CBP | PCB |
| CBP | 9 | 5 | 1 | ||||
| CNBI | 4 | 1 | |||||
| CNBNI | 2 | 1 | 1 | 1 | |||
| C&CBP | 4 | 1 | |||||
| PCB | 1 | 1 | |||||
| Group C: 2 glass test | T | U | CBP | CNBI | CNBNI | C&CBP | PCB |
| CBP | 6 | 1 | 2 | ||||
| CNBI | 2 | 1 | 1 | ||||
| CNBNI | |||||||
| C&CBP | 2 | 1 | |||||
| PCB | 2 | 1 |
| 4GT | 3GT | 2GT | 4GT vs 3GT (p) |
4GT vs 2GT (p) |
3GT vs 2GT (p) |
|
|---|---|---|---|---|---|---|
| Patients with CBP (N) |
16 | 29 | 14 | 0.19 | 0.23 | 0.91 |
| Total patients tested (N) | 59 | 67 | 31 |
| 4GT | 3GT | 2GT | 4GT vs 3GT (p) |
4GT vs 2GT (p) |
3GT vs 2GT (p) |
|
|---|---|---|---|---|---|---|
| Patients with CBP (N) |
16 | 29 | 14 | 0.22 | 0.27 | 0.99 |
| Total patients tested (N) | 59 | 67 | 31 |
| 4 glass test |
3 glass test | 2 glass test | ||||
|---|---|---|---|---|---|---|
|
Enterococcus faecalis |
13 |
Escherichia coli |
25 |
Enterococcus faecalis |
4 | |
|
Escherichia coli |
12 |
Enterococcus faecalis |
17 |
Escherichia coli |
4 | |
|
Staphylococcus epidermidis |
4 |
Proteus mirabilis |
10 |
Staphylococcus epidermidis |
3 | |
|
Staphylococcus hominis |
4 |
Staphylococcus epidermidis |
9 |
Staphylococcus hominis |
2 | |
|
Staphylococcus haemolyticus |
3 |
Staphylococcus hominis |
4 |
Staphylococcus haemolyticus |
1 | |
|
Klebsiella aerogenes |
2 |
Streptococcus agalactiae |
3 |
Klebsiella aerogenes |
1 | |
|
Staphylococcus lugdunensis |
1 |
Haemophilus parainfluenza |
2 | |||
| Pantoea sp | 1 |
Enterococcus Faecium |
1 | |||
|
Staphylococcus capitis |
1 |
Klebsiella aerogenes |
1 | |||
| Gonococcus | 1 | |||||
| 4GT | 3GT | 2GT | ||||
| Full sensitive | 32 | 29 | 11 | |||
| Any resistance | 9 | 44 | 4 | |||
| Total | 41 | 73 | 15 | |||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).